Two extended-spectrum mutants of the class D β-lactamase OXA-10 (PSE-2) from
Pseudomonas aeruginosa isolates obtained in Ankara, Turkey, were described previously …

Pseudomonas aeruginosa ED-1, isolated from a pulmonary brush of a patient hospitalized
in a suburb of Paris, France, was resistant to ceftazidime and of intermediate susceptibility to …

Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI 6.2 beta-
lactamase determined by plasmid pMLH53 and resisted all beta-lactams except …

Pseudomonas aeruginosa clinical isolate PA35 is resistant to amino-and ureido-penicillins,
has intermediate susceptibility to cefsulodin, cefepime and aztreonam, and is susceptible to …

Pseudomonas aeruginosa AH, isolated in Ankara, Turkey, was highly resistant to
ceftazidime (MIC, 128 microg/ml) and produced a beta-lactamase that gave a doublet of …

Pseudomonas aeruginosa isolates 871 and 873 were isolated at Hacettepe University
Hospital in Ankara and were highly resistant to ceftazidime (MIC, 128 μg/ml). Each produced …

Several extended-spectrum β-lactamases (ESBLs) belonging to molecular Class D have
been described from Pseudomonas aeruginosa isolates collected in Turkey. Four of these …

ABSTRACT A clinical isolate of Pseudomonas aeruginosa, PAe191, was found to be highly
resistant to all anti-Pseudomonas β-lactam antibiotics (except imipenem) and resistant also …

Pseudomonas aeruginosa ABD, which was isolated in October 1991 from blood cultures of
a burn patient in Turkey, was resistant to cephalosporins, particularly ceftazidime (MIC, 512 …

Objectives To describe a novel extended-spectrum oxacillinase, named OXA-145, differing
from narrow-spectrum OXA-35 (from the OXA-10 group) by deletion of residue Leu-165. The …